Larimar Therapeutics, Inc. · NASDAQ:LRMR

Deerfield Management Company, L.P. reported a 35.81% stake in Larimar Therapeutics, Inc. (Schedule 13D/A)

Event Jul 31, 2025 · Filed Jul 31, 2025

Deerfield Management Company, L.P. reported a 35.81% stake in Larimar Therapeutics, Inc., 30,667,474 shares, with active intent on Jul 31, 2025. Filed Jul 31, 2025 (Schedule 13D/A).

Stake
35.81%
Shares
30,667,474
Intent
Active
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
Deerfield Private Design Fund III, L.P.11.14%9,538,918
Deerfield Healthcare Innovations Fund, L.P.8.55%7,321,129
Deerfield Private Design Fund IV, L.P.11.14%9,538,945
Deerfield Partners, L.P.4.91%4,207,982
Deerfield Mgmt III, L.P.11.14%9,538,918
Deerfield Mgmt HIF, L.P.8.55%7,321,129
Deerfield Mgmt IV, L.P.11.14%9,538,945
Deerfield Mgmt, L.P.4.91%4,207,982
Deerfield Management Company, L.P.35.81%30,667,474
James E. Flynn35.81%30,667,474

Source

View original at SEC

Related